Acadia Healthcare (ACHC)
(Delayed Data from NSDQ)
$73.38 USD
+2.19 (3.08%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $73.41 +0.03 (0.04%) 6:52 PM ET
3-Hold of 5 3
C Value B Growth F Momentum B VGM
Acadia Healthcare (ACHC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$95.58 | $105.00 | $70.00 | 34.26% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Acadia Healthcare comes to $95.58. The forecasts range from a low of $70.00 to a high of $105.00. The average price target represents an increase of 34.26% from the last closing price of $71.19.
Analyst Price Targets (12)
Broker Rating
Acadia Healthcare currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.75 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, eight are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 66.67% and 8.33% of all recommendations. A month ago, Strong Buy made up 66.67%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 7 | 7 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.75 | 1.75 | 1.75 | 1.82 | 1.82 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/6/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Hold | Hold |
2/29/2024 | Cantor Fitzgerald & Co | Sarah James | Hold | Hold |
1/5/2024 | Stephens | Scott Fidel | Hold | Strong Buy |
11/6/2023 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
11/3/2023 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 12 |
Average Target Price | $95.58 |
LT Growth Rate | 9.50% |
Industry | Medical - Hospital |
Industry Rank by ABR | 17 of 252 |
Current Quarter EPS Est: | 0.80 |